T1	Participants 51 83	acute myeloid leukemia patients.
T2	Participants 602 695	(the German AML Cooperative Group and the Dutch-Belgian Hematology Oncology Cooperative group
T3	Participants 698 806	IHC (n = 84), ELISAs of blood/BM sera (n = 41), and microarray data for mRNA levels (n = 261) were performed
